lifestyle.celebhomes.net
Home
Sample Page
Author:
Mezzion Pharmaceuticals, Inc
Mezzion Reports Pre-IND FDA Feedback on the Development of Udenafil in ADPKD
May 7, 2026
Mezzion Pharmaceuticals Applauds Give Kids a Chance Act Becoming Law
February 5, 2026
Mezzion Pharmaceuticals Appoints Physician-Scientist Ridwan Shabsigh, MD, FACS as President & Chief Operating Officer
January 6, 2026
Mezzion Announces U.S. Patent Allowance Strengthening Udenafil Exclusivity in Fontan Patients
December 4, 2025